Novel ATP8B1 Gene Mutations in a Child with Progressive Familial Intrahepatic Cholestasis Type 1
10.5223/pghn.2019.22.5.479
- Author:
Eun Sang RHEE
1
;
Yu Bin KIM
;
Sunghee LEE
;
Seak Hee OH
;
Beom Hee LEE
;
Kyung Mo KIM
;
Han Wook YOO
Author Information
1. Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Korea. seakhee.oh@amc.seoul.kr
- Publication Type:Case Report
- Keywords:
Intrahepatic cholestasis;
ATP8B1;
Child
- MeSH:
Child;
Cholestasis;
Cholestasis, Intrahepatic;
Fatty Liver;
Genetic Testing;
Humans;
Korea;
Liver Cirrhosis, Biliary;
Liver Failure;
Liver Transplantation;
Steatorrhea;
Transferases
- From:Pediatric Gastroenterology, Hepatology & Nutrition
2019;22(5):479-486
- CountryRepublic of Korea
- Language:English
-
Abstract:
Progressive familial intrahepatic cholestasis (PFIC) is a group of severe genetic disorders, inherited in an autosomal recessive manner, causing cholestasis of hepatocellular origin, later progressing to biliary cirrhosis and liver failure. This is the first report of PFIC type 1 with novel compound heterozygous mutations in Korea. The patient was presented with intrahepatic cholestasis, a normal level of serum γ-glutamyl transferase, steatorrhea, and growth failure. Genetic testing of this patient revealed novel compound heterozygous mutations (p.Glu585Ter and p.Leu749Pro) in the ATP8B1 gene. After a liver transplantation at age 19 months, the patient developed severe post-transplant steatohepatitis.
